Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
![Foto de Unidade de Investigación en Cardioloxía Celular e Molecular](/img/grupo.png)
![Foto de Universidade da Coruña](/img/noimage_org.png)
Universidade da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Universidade da Coruña (25)
2024
-
Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial
Progress in Cardiovascular Diseases
-
Videolaryngoscope versus conventional technique for insertion of a transesophageal echocardiography probe in intubated ICU patients (VIDLARECO trial): A randomized clinical trial
Anaesthesia Critical Care and Pain Medicine, Vol. 43, Núm. 2
2022
-
Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study
Cardiology Journal, Vol. 29, Núm. 5, pp. 798-806
-
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252
-
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology, Vol. 13
-
Thirty-second sit-to-stand test as an alternative for estimating peak oxygen uptake and 6-min walking distance in women with breast cancer: a cross-sectional study
Supportive Care in Cancer, Vol. 30, Núm. 10, pp. 8251-8260
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
-
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
FASEB Journal, Vol. 35, Núm. 7
2020
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
2019
-
Colombian consensus on advanced heart failure: Heart Failure, Heart Transplant and Pulmonary Hypertension Section of Colombian Society of Cardiology and Cardiovascular Surgery
Revista Colombiana de Cardiologia, Vol. 26, pp. 3-24
-
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
Biochemical Pharmacology, Vol. 170
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2018
-
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis
Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562
2017
-
Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort
Medicine (United States), Vol. 96, Núm. 38
2015
-
Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: Reducing risk of heart failure patients in noncardiac surgery
Revista Espanola de Anestesiologia y Reanimacion, Vol. 62, Núm. 7, pp. 359-419
-
Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study
Medicine (United States), Vol. 94, Núm. 43
-
Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: Documento de consenso
Atencion Primaria